Gottlieb's Complex Generics Remarks Could Signal (Some) Increased Flexibility

US FDA commissioner spoke to agency scientists and researchers at Generic Drug Science Day, where he discussed future plans to facilitate complex generic development.

More from Generics

More from Biosimilars & Generics